Cargando…
Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective
Autor principal: | Okumura, Lucas Miyake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427565/ https://www.ncbi.nlm.nih.gov/pubmed/27094235 http://dx.doi.org/10.1016/j.bjid.2016.03.006 |
Ejemplares similares
-
Histoplasmosis in HIV-Infected Persons, Yaoundé, Cameroon
por: Mandengue, Christine E., et al.
Publicado: (2015) -
Oral histoplasmosis
por: Momesso, Gustavo Antonio Correa, et al.
Publicado: (2017) -
Subacute progressive disseminated histoplasmosis in immunocompetent patient
por: Choi, Seong Jin, et al.
Publicado: (2016) -
Hemophagocytic Lymphohistiocytosis and Progressive Disseminated Histoplasmosis
por: Ferguson-Paul, Kenice, et al.
Publicado: (2016) -
Azole-Resistant Aspergillus fumigatus, Iran
por: Seyedmousavi, Seyedmojtaba, et al.
Publicado: (2013)